-+ 0.00%
-+ 0.00%
-+ 0.00%

Diamyd Medical Reports Second Quarter 2025 Earnings

Simply Wall St·04/10/2025 04:41:43
Listen to the news

Diamyd Medical (STO:DMYD B) Second Quarter 2025 Results

Key Financial Results

  • Net loss: kr44.9m (loss widened by 53% from 2Q 2024).
earnings-and-revenue-history
OM:DMYD B Earnings and Revenue History April 10th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Diamyd Medical Earnings Insights

Looking ahead, revenue is forecast to grow 116% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Biotechs industry in Sweden.

Performance of the Swedish Biotechs industry.

The company's shares are down 2.5% from a week ago.

Risk Analysis

We should say that we've discovered 6 warning signs for Diamyd Medical (3 shouldn't be ignored!) that you should be aware of before investing here.